China’s Black Market Stem Cells

Despite government efforts to ban unapproved stem cell treatments, companies around China still offer them openly.

Megan Scudellari
Apr 13, 2012

WIKIMEDIA COMMONS, CALLE EKLUND/V-WOLF

In January, the Chinese Ministry of Health once again attempted to regulate the unapproved stem-cell tourism business in China, announcing rules such as required registration for organizations using stem cells in the clinic and a halt to any unapproved stem cell treatments. But not a single clinic has registered, and business is still booming, according to an investigation by Nature.

The clinics, which operate openly, offer expensive and unapproved stem cell treatments for Parkinson’s disease, diabetes, and autism, among other disorders, and attract thousands of medical tourists from around the world. The Chinese health ministry has made several attempts to ban the treatments, including classifying stem-cell treatments as “high risk” and requiring the approval of a technical audit board, but to no avail.

The clinics all claim success in treating patients, but none has published data from controlled clinical trials, Nature reported. And every stem-cell...

A Ministry of Health representative told Nature that the Ministry is working to take steps to regulate the industry.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?